Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Abhydrolase domain-containing protein 12B (ABHD12B) is a protein coding gene in humans belonging to the alpha/beta hydrolase domain-containing family, similar to its paralog ABHD12[3]. It is predicted to function as a lysophospholipase and monoacylglycerol lipase, participating in lipid metabolic processes such as the catabolism of monoacylglycerol and phosphatidylserine[3]. The protein localizes to the endoplasmic reticulum membrane. Mutations or alterations in ABHD12B have been associated with rare conditions such as aggressive periodontitis and Chanarin-Dorfman syndrome, but its precise physiological and pathological roles are still being elucidated[3]. The protein is structurally related to ABHD12, which is known to be a major lysophosphatidylserine lipase in the brain and is implicated in neurological processes, but there are no published data that directly implicate ABHD12B in these central nervous system functions or in the same set of diseases as ABHD12, such as PHARC[1][3].
Not established; based on gene family, likely involves inhibition of lysophospholipase or monoacylglycerol lipase activity[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Abhydrolase domain-containing protein 12B (ABHD12B).